NCT00532207View on ClinicalTrials.gov

Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

December 31, 2004

Conditions

Osteoporosis, Post-Menopausal

Interventions

DRUG

teriparatide

subcutaneous 20 micrograms

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Moscow

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00532207 - Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis | Biotech Hunter | Biotech Hunter